Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Fetal fibronectin testing for reducing the risk of preterm birth

This is not the most recent version

view the current version 29 July 2019

Information

DOI:
https://doi.org/10.1002/14651858.CD006843.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 08 October 2008see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:

  1. Cochrane Pregnancy and Childbirth Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Vincenzo Berghella

    Correspondence to: Director, Division of Maternal Fetal Medicine, Thomas Jefferson University, Philadelphia, USA

    [email protected]

  • Edward Hayes

    Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, USA

  • John Visintine

    Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, USA

  • Jason K Baxter

    Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, USA

Contributions of authors

Jason K. Baxter, Edward Hayes, and John Visintine:
1. helped with the initial idea of a fetal fibronectin review;
2. met several times with the main author (Vincenzo Berghella (VB)) regarding all aspects of the development of the protocol and review;
3. contributed to the writing and the editing of the protocol and the review;
4. helped to revise and respond to the feedback received on the first draft of the protocol and the review.

VB prepared the first draft and finalised the revised draft of the protocol and the review in response to feedback. VB is the guarantor of the review. 

Declarations of interest

available in

None known.

Acknowledgements

available in

Sonja Henderson and Jolene Seibel‐Seamon, MD, for advice and support through the protocol and review process.

As part of the pre‐publication editorial process, this review has been commented on by three peers (an editor and two referees who are external to the editorial team), a member of the Pregnancy and Childbirth Group's international panel of consumers and the Group's Statistical Adviser.

Version history

Published

Title

Stage

Authors

Version

2019 Jul 29

Fetal fibronectin testing for reducing the risk of preterm birth

Review

Vincenzo Berghella, Gabriele Saccone

https://doi.org/10.1002/14651858.CD006843.pub3

2008 Oct 08

Fetal fibronectin testing for reducing the risk of preterm birth

Review

Vincenzo Berghella, Edward Hayes, John Visintine, Jason K Baxter

https://doi.org/10.1002/14651858.CD006843.pub2

2007 Oct 17

Fetal fibronectin testing for reducing the risk of preterm birth

Protocol

Vincenzo Berghella, Edward Hayes, John Visintine, Jason Baxter

https://doi.org/10.1002/14651858.CD006843

Differences between protocol and review

None.

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.